
Natco Pharma Limited has informed the Exchange regarding a press release dated December 21, 2023, titled "Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015".
Filed with NSE ·

Natco Pharma Limited has informed the Exchange regarding a press release dated December 21, 2023, titled "Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015".
6ix hasn’t read this filing yet.
Follow NATCO Pharma into a list and get an email when it puts out news.
Follow NATCO Pharma